Dynamic Transcription Factor Networks in Epithelial-Mesenchymal Transition in Breast Cancer Models

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Siletz, Anaar ^a,b   Schnabel, Michael ^c   Kniazeva, Ekaterina ^a   Schumacher, Andrew J ^b   Shin, Seungjin ^a   Jeruss, Jacqueline S ^b   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INVASION; CELL STRAIN MCF 7; CLUSTER ANALYSIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MATHEMATICAL ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN FUNCTION;

BREAST NEOPLASMS; CLUSTER ANALYSIS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MCF-7 CELLS; MODELS, BIOLOGICAL; PROTEIN ARRAY ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84875980031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057180     Document Type: Article

References (71)

1. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, et al. (2008) Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 130: 481-494.
2. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
3. Micalizzi DS, Farabaugh SM, Ford HL, (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134.
4. Neilson EG (2010) The Jeremiah Metzger lecture. The origin of fibroblasts and the terminality of epithelial differentiation. Trans Am Clin Climatol Assoc 121: 240-250; discussion 250-241.
5. Foubert E, De Craene B, Berx G, (2010) Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression. Breast Cancer Res 12: 206.
6. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
7. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
8. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, et al. (2009) Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69: 2887-2895.
9. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
10. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
11. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, et al. (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: 123-151.
12. Kim HD, Meyer AS, Wagner JP, Alford SK, Wells A, et al. (2011) Signaling network state predicts Twist-mediated effects on breast cell migration across diverse growth factor contexts. Mol Cell Proteomics.
13. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, et al. (2011) A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28: 137-155.
14. Turner C, Kohandel M (2012) Quantitative approaches to cancer stem cells and epithelial-mesenchymal transition. Semin Cancer Biol.
15. Venkov C, Plieth D, Ni T, Karmaker A, Bian A, et al. (2011) Transcriptional networks in epithelial-mesenchymal transition. PLoS One 6: e25354.
16. Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, et al. (2011) An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS One 6: e17083.
17. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107: 15449-15454.
18. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
19. Min C, Eddy SF, Sherr DH, Sonenshein GE, (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
20. Moustakas A, Heldin CH, (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
21. Xu J, Lamouille S, Derynck R, (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172.
22. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
23. Quaggin SE, Kapus A, (2011) Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 80: 41-50.
24. Blais A, Dynlacht BD, (2005) Constructing transcriptional regulatory networks. Genes Dev 19: 1499-1511.
25. Gotea V, Visel A, Westlund JM, Nobrega MA, Pennacchio LA, et al. (2010) Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res 20: 565-577.
26. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, et al. (2010) An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140: 744-752.
27. Tkacik G, Walczak AM, (2011) Information transmission in genetic regulatory networks: a review. J Phys Condens Matter 23: 153102.
28. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
29. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499-511.
30. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
31. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, et al. (2001) A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 276: 27424-27431.
32. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
33. Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, et al. (2006) Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66: 9543-9556.
34. Weiss MS, Penalver Bernabe B, Bellis AD, Broadbelt LJ, Jeruss JS, et al. (2010) Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS One 5: e14026.
35. Siletz A, Kniazeva E, Jeruss JS, Shea LD (2012) Transcription Factor Networks in Invasion-Promoting Breast Carcinoma-Associated Fibroblasts. Cancer Microenviron.
36. Team RDC (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing.
37. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378.
38. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, et al. (2009) The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 4: 1591-1613.
39. Dubois-Marshall S, Thomas JS, Faratian D, Harrison DJ, Katz E, (2011) Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer. Clin Exp Metastasis 28: 811-818.
40. Katz E, Verleyen W, Blackmore CG, Edward M, Smith VA, et al. (2011) An analytical approach differentiates between individual and collective cancer invasion. Anal Cell Pathol (Amst) 34: 35-48.
41. Klymkowsky MW, Savagner P, (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174: 1588-1593.
42. Bonavida B, Baritaki S, (2011) The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-kappaB/Snail/YY1/RKIP/PTEN Circuitry. Crit Rev Oncog 16: 211-226.
43. Dhasarathy A, Kajita M, Wade PA, (2007) The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 21: 2907-2918.
44. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, et al. (2008) ERalpha suppresses slug expression directly by transcriptional repression. Biochem J 416: 179-187.
45. Xi C, Hu Y, Buckhaults P, Moskophidis D, Mivechi NF (2012) Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) to Promote Mammary Tumorigenesis and Metastasis. J Biol Chem.
46. Jiang J, Tang YL, Liang XH, (2011) EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 11: 714-723.
47. Fernando RI, Litzinger M, Trono P, Hamilton DH, Schlom J, et al. (2010) The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 120: 533-544.
48. Roselli M, Fernando RI, Guadagni F, Spila A, Alessandroni J, et al. (2012) Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer. Clin Cancer Res 18: 3868-3879.
49. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102: 3738-3743.
50. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, et al. (2004) Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2: E7.
51. Farnham PJ, (2009) Insights from genomic profiling of transcription factors. Nat Rev Genet 10: 605-616.
52. Barabasi AL, Oltvai ZN, (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
53. Veiga DF, Dutta B, Balazsi G, (2010) Network inference and network response identification: moving genome-scale data to the next level of biological discovery. Mol Biosyst 6: 469-480.
54. Ramis-Conde I, Drasdo D, Anderson AR, Chaplain MA, (2008) Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach. Biophys J 95: 155-165.
55. Dutta B, Pusztai L, Qi Y, Andre F, Lazar V, et al. (2012) A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer 106: 1107-1116.
56. Wasserman WW, Sandelin A, (2004) Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 5: 276-287.
57. Sharon E, Kalma Y, Sharp A, Raveh-Sadka T, Levo M, et al. (2012) Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters. Nat Biotechnol 30: 521-530.
58. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA, (2011) The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS One 6: e26514.
59. Li Z, Wang N, Fang J, Huang J, Tian F, et al. (2012) Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells. Oncol Rep 27: 1879-1886.
60. McDonnell DP, Wardell SE, (2010) The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Curr Opin Pharmacol 10: 620-628.
61. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e2888.
62. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68: 989-997.
63. Jiang X, Roth L, Lai C, Li X, (2006) Profiling activities of transcription factors in breast cancer cell lines. Assay Drug Dev Technol 4: 293-305.
64. Lopez-Novoa JM, Nieto MA, (2009) Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1: 303-314.
65. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, et al. (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940.
66. Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM, (2012) Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30: 292-303.
67. Baker SG, Kramer BS, (2011) Systems biology and cancer: promises and perils. Prog Biophys Mol Biol 106: 410-413.
68. Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, et al. (2009) A systems biology view of cancer. Biochim Biophys Acta 1796: 129-139.
69. Blick T, Hugo H, Widodo E, Waltham M, Pinto C, et al. (2010) Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 15: 235-252.
70. Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D, (2012) A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One 7: e34705.
71. Neagu A, Mironov V, Kosztin I, Barz B, Neagu M, et al. (2010) Computational modeling of epithelial-mesenchymal transformations. Biosystems 100: 23-30.